The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata

By Ucak Haydar   Kandi Basak   Cicek Demet   Halisdemir Nurhan   Dertlİoğlu Selma Bakar  

Journal of Dermatological Treatment, Vol. 23, Iss. 6, 2012-12 ,pp. : 410-420

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata

By Kim Beom Joon   Uk min Seong   Park Kui Young   Choi Jung Won   Park Sung Wook   Youn Sang Woong   Park Kyoung Chan   Huh Chang Hun  

Journal of Dermatological Treatment, Vol. 19, Iss. 4, 2008-01 ,pp. : 216-220

Informa Healthcare

Access to resources Recommend Favorite

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

By Au Shiu-Chung  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Pulse methylprednisolone therapy for the treatment of extensive alopecia areata

By Açıkgöz Gürol   Özmen İbrahim   Çayırlı Mutlu   Yeniay Yıldıray   Köse Osman  

Journal of Dermatological Treatment, Vol. 25, Iss. 2, 2014-04 ,pp. : 164-166

Informa Healthcare

Access to resources Recommend Favorite

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

By Roblin David   Yosipovitch Gil   Boyce Brent   Robinson John   Sandy James   Mainero Valentina   Wickramasinghe Ro   Anand Uma   Anand Praveen  

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 542-548

Medical Journals Limited

Access to resources Recommend Favorite